Moderna is a biotechnology company that is revolutionizing the healthcare industry. Founded in 2010, this Massachusetts-based company is on the cutting edge of medical research, developing groundbreaking treatments and vaccines for diseases like COVID-19. But who are the people behind this innovative company? From the scientists behind their products to the executives steering the ship, meet the people who make Moderna possible.
Moderna is an American biotechnology company based in Cambridge, Massachusetts. Founded in 2010 by Flagship Pioneering, the company has developed a platform technology that enables it to rapidly create and develop mRNA medicines for a range of diseases. Moderna is developing treatments and preventative vaccines for infectious diseases, cancer, and rare disorders. As of 2020, Moderna has developed over 25 messenger RNA (mRNA) therapeutics and vaccines. It is funded by venture capital firms and strategic partners, including AstraZeneca, Vertex Pharmaceuticals, Merck, and Alexion Pharmaceuticals.
Who Makes Moderna?
Moderna is a pioneering biotechnology company that specializes in the development of messenger RNA (mRNA) therapeutics and vaccines. Founded in 2010, Moderna has quickly become one of the most successful biotechnology companies in the world. It is headquartered in Cambridge, Massachusetts and is publicly traded on the Nasdaq stock exchange.
Moderna’s Executive Team
Moderna is led by a diverse and experienced executive team. These are the people who make up the company’s leadership:
- Stéphane Bancel, Chief Executive Officer
- Tal Zaks, Chief Medical Officer
- Brett Rose, Chief Financial Officer
- Lorence Kim, Senior Vice President of Development
- Hilary Vernon, Senior Vice President of Corporate Strategy and Business Development
- David M. Jones, Senior Vice President and Chief Information Officer
- Timothy J. Rodell, Senior Vice President and Chief Legal and Compliance Officer
- José Szapocznik, Senior Vice President of Process Sciences and Manufacturing
- Jorge Morales-Oyarvide, Senior Vice President of Technical Operations
Moderna’s Board of Directors
Moderna’s board of directors is composed of experienced and accomplished industry leaders from a variety of backgrounds. These are the people who help guide the company’s strategic direction:
- Robert Langer, Co-founder and Chairman
- Stéphane Bancel, Chief Executive Officer
- Robert Coughlin, Founder and President of Massachusetts Biotechnology Council
- John Maraganore, Chief Executive Officer of Alnylam Pharmaceuticals
- Robert Nelsen, Co-founder and Managing Director of Arch Venture Partners
- John W. Thompson, Chairman of Microsoft Corporation
- Vijay L. Sankaran, Chief Operating Officer of the Bill & Melinda Gates Foundation
- Douglas M. Cole, Managing Director of Flagship Pioneering
- Lorence Kim, Senior Vice President of Development at Moderna
- John Desjarlais, Senior Vice President of Research at Sanford Burnham Prebys Medical Discovery Institute
Moderna’s Strategic Partners
Moderna has established strategic partnerships with a number of leading companies, organizations, and institutions. These strategic partners provide expertise, access to technology and capital, and other resources that help Moderna to develop new treatments and vaccines.
- Merck
- Vaccinex
- AstraZeneca
- Vertex Pharmaceuticals
- Sanofi
- Biogen
- Novartis
- The National Institutes of Health
- The Bill & Melinda Gates Foundation
- Barclays
Related FAQ
Who is Moderna?
Moderna is a biotechnology company based in Cambridge, Massachusetts, that specializes in the development of messenger RNA (mRNA) therapeutics and vaccines. The company was founded in 2010 by Stéphane Bancel and Derrick Rossi and has since become a leader in mRNA-based drug development. Moderna’s mRNA-based drug candidates are designed to target a wide range of diseases, and they are currently working on a vaccine for the novel coronavirus, SARS-CoV-2.
What is Moderna’s mission?
Moderna’s mission is to transform the lives of patients and to bring innovative medicines to the world. The company is focused on developing therapies and vaccines that use mRNA technology to target diseases that have no existing treatments, with the ultimate goal of improving people’s lives.
Who are Moderna’s founders?
Moderna was founded in 2010 by Stéphane Bancel and Derrick Rossi. Bancel is the current CEO of the company, and Rossi is Moderna’s Chief Scientific Officer. Both Bancel and Rossi have extensive experience in the biotechnology industry and have been instrumental in helping Moderna become a leader in mRNA-based drug development.
What kind of products does Moderna produce?
Moderna produces mRNA-based therapeutics and vaccines that are designed to target a wide range of diseases. The company is currently working on a vaccine for the novel coronavirus, SARS-CoV-2, and has a number of other products in development. In addition, Moderna also produces platform technologies, such as its proprietary lipid nanoparticle (LNP) delivery system, that are designed to improve the effectiveness of its drugs.
What have been some of Moderna’s major accomplishments?
Moderna has achieved some major milestones since its founding in 2010. In 2012, the company successfully completed its first clinical trial, and in 2015, it received its first FDA approval for a drug. Since then, Moderna has continued to expand its product pipeline and has become a leader in mRNA-based drug development. Most recently, the company was selected by the US government to develop a vaccine for the novel coronavirus, SARS-CoV-2.
Where is Moderna located?
Moderna is located in Cambridge, Massachusetts. The company has a number of other locations around the world, including offices in California, Switzerland, and Singapore.
Moderna is a biotechnology company that is at the forefront of developing innovative treatments and vaccines for a wide range of diseases. The company is powered by a talented, diverse team of scientists, engineers, and business professionals who are passionate about improving the health and well-being of people around the world. With their dedication, commitment, and expertise, Moderna is making a real, tangible impact on global health and helping to shape the future of medicine.